Fifth Third Bancorp
COCP icon

Fifth Third Bancorp’s Cocrystal Pharma COCP Stock Holding History

Fifth Third Bancorp’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-694
Closed -$23K – 2271
2019
Q1 		$23K Hold
694
– – ﹤0.01% 1533
2018
Q4 		$30K Hold
694
– – ﹤0.01% 1399
2018
Q3 		$21K Hold
694
– – ﹤0.01% 1624
2018
Q2 		$30K Hold
694
– – ﹤0.01% 1500
2018
Q1 		$50K Buy
+694
New +$43.3K ﹤0.01% 1326

Other funds holding COCP

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fifth Third Bancorp's COCP Position: Q2 2019 in Review

Fifth Third Bancorp sold out of Cocrystal Pharma (COCP) in Q2 2019, closing a stake of 694 shares — an estimated $23K sold.

Fifth Third Bancorp first reported a position in COCP in Q1 2018 and held it in 5 quarters. The position peaked at $50K in Q1 2018. 18 funds tracked by Wall St. Rank hold COCP as of Q2 2019.

  • Fifth Third Bancorp reported no remaining Cocrystal Pharma position as of Q2 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 694 Cocrystal Pharma shares in Q2 2019, an estimated $23K.
  • Fifth Third Bancorp first reported a position in Cocrystal Pharma in Q1 2018 and held it in 5 quarters.
  • Fifth Third Bancorp's Cocrystal Pharma position peaked at $50K in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2019.

Based on Fifth Third Bancorp's 13F filing for Q2 2019, filed 7 Aug 2019.